-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
20
2025-07
To comprehensively summarize the achievements and shortcomings of the first half of the year, deeply analyze industry development trends, and outline key tasks and future strategic plans for the second half, Keyuan Pharmaceutical grandly held its semi-annual management cadre review meeting on July 19, rallying collective consensus and committing fully to achieving the annual goals.
2025-07-20
11
2025-07
To further enhance the company's operational management capabilities and strengthen the team's understanding and application of the Lean Management System, Keyuan Pharmaceutical (stock code: 301281.SZ) recently invited Liu Xingcun, Vice President of the Group and Dean of the Digital Intelligence Application Research Institute, to deliver a specialized training session themed "Corporate Business Strategy Management." This initiative aims to help team members deepen their insight into the company's business logic, master the methodology and relevant tools for strategy management, and ultimately inject new momentum into the company's high-quality development.
2025-07-11
01
2025-07
This exercise was conducted under the principles of "realistic simulation and practical effectiveness," replicating a scenario where a hazardous chemical leak triggers a fire accident. Lin Yan, EHS Vice President, along with employees from all departments across various plants, actively participated. All participants worked together seamlessly, successfully completing the exercise mission.
2025-07-01
24
2025-06
On the eve of the exhibition opening, Gao Chunpo, Chairman and President of Keyuan Pharmaceutical, personally led the international marketing team to host an international VIP client symposium, fostering in-depth communication and exchanges with partners from around the globe.
2025-06-24
21
2025-06
This competition featured two events: men's singles and women's singles, both of which attracted a large number of participants eager to compete. At the venue, athletes wholeheartedly embraced the competitive spirit of "Friendship First, Competition Second," engaging in lively exchanges and friendly rivalry as they expertly wielded their rackets. Throughout the matches, countless thrilling reversals, dazzling smashes, spectacular fast breaks, and exhilarating rallies unfolded one after another, vividly showcasing the players' passion and strategic brilliance.
2025-06-21
20
2025-06
From June 18 to 19, Cai Yujie, founder and director of Xi'an Zhuohong Chaoyuan Biotechnology Co., Ltd., and his delegation visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. The two sides engaged in in-depth discussions covering production line construction, technology R&D, and market insights, laying the foundation for exploring new avenues of collaborative industrial development.
2025-06-20
14
2025-06
To continuously enhance quality management and strengthen employees' awareness of quality risk prevention, ensuring the company strictly adheres to GMP standards, Keyuan Pharmaceutical (stock code: 301281.SZ) organized a two-day self-inspection of its pharmaceutical production quality management from June 12 to 13. The inspection was conducted with rigorous, practical, and comprehensive coverage, using stringent criteria to drive continuous improvement in quality management—and reflecting the company's strong commitment to drug safety.
2025-06-14
12
2025-06
In response to the call for the 24th National "Safety Production Month" campaign, and to effectively enhance the company's ability to handle emergencies and unexpected injuries, Keyuan Pharmaceutical (stock code: 301281.SZ) joined forces with the Shanghe County Red Cross Society on June 12 to meticulously organize a specialized emergency first-aid training session tailored for certified first responders. Dozens of company employees enthusiastically participated, and all trainees successfully passed the assessment, earning their Red Cross-certified first-aid qualifications.
2025-06-12
12
2025-06
Recently, Zhu Tongseng, General Manager of Hangzhou Deli Chemical Co., Ltd., led a team on a visit to Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection tour and collaborative discussions. The two companies engaged in in-depth conversations covering topics such as production equipment, technology sharing, and market resource integration, aiming to establish a long-term strategic partnership that will foster mutual benefits and win-win outcomes. Accompanying the delegation were Gao Chunpo, Chairman and President of Keyuan Pharmaceutical, along with Wu Zhongyu, Dean of the Research Institute, among others.
2025-06-12
09
2025-06
Recently, Keyuan Pharmaceutical held a special seminar at its Research Institute, focusing on an in-depth discussion of the company's R&D strategy, project advancement, and operational management. Chairman and President Gao Chunpo, along with the senior management team, heads of the Research Institute, and leaders of various project teams, attended the meeting. The session aimed to optimize R&D management, strengthen quality control, enhance R&D efficiency, and foster a deeper integration of R&D initiatives with the company's overall business strategy—thereby injecting strong momentum into the firm's long-term growth and development.
2025-06-09
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline